T1	tradename 0 6	BEXXAR
T3	activeingredient 8 19	tositumomab
T5	nanoparticle 24 49	iodine I 131 tositumomab)
T7	tradename 157 163	BEXXAR
T9	tradename 226 241	BEXXAR. BEXXAR
T11	activeingredient 243 254	tositumomab
T13	nanoparticle 259 284	iodine I 131 tositumomab)
T15	routeofadministration 300 311	intravenous
T17	fdaapprovaldate 344 348	2003
T19	adversereaction 528 547	Allergic Reactions:
T21	tradename 611 617	BEXXAR
T23	adversereaction 650 668	allergic reactions
T25	tradename 733 739	BEXXAR
T27	tradename 935 941	BEXXAR
T29	tradename 1550 1556	BEXXAR
T31	activeingredient 1558 1569	tositumomab
T33	nanoparticle 1574 1599	Iodine I 131 tositumomab)
T35	chemoclass 1605 1618	CD20-directed
T37	indication 1768 1786	Hodgkin's lymphoma
T39	indication 1887 1910	non-Hodgkin's lymphoma.
T41	tradename 1960 1966	BEXXAR
T43	tradename 2113 2119	BEXXAR
T45	tradename 2202 2208	BEXXAR
T47	tradename 2408 2414	BEXXAR
T49	tradename 2603 2603	
T51	activeingredient 2603 2614	Tositumomab
T53	tradename 2668 2668	
T55	activeingredient 2668 2679	Tositumomab
T57	tradename 2732 2732	
T59	nanoparticle 2732 2756	Iodine I 131 tositumomab
T61	activeingredient 2787 2797	Iodine-131
T63	activeingredient 2869 2880	tositumomab
T65	tradename 2942 2942	
T67	nanoparticle 2942 2966	Iodine I 131 tositumomab
T69	activeingredient 2999 3009	Iodine-131
T71	activeingredient 3078 3089	tositumomab
T73	tradename 3510 3516	BEXXAR
T75	adversereaction 4141 4152	neutropenia
T77	adversereaction 4154 4170	thrombocytopenia
T79	adversereaction 4172 4178	anemia
T81	adversereaction 4180 4190	infections
T83	adversereaction 4192 4210	infusion reactions
T85	adversereaction 4212 4220	asthenia
T87	adversereaction 4222 4227	fever
T89	adversereaction 4233 4240	nausea.
T91	tradename 4294 4294	
T93	company 4294 4309	GlaxoSmithKline
T95	tradename 6638 6644	BEXXAR
T97	tradename 6781 6787	BEXXAR
T99	tradename 6960 6966	BEXXAR
T101	tradename 7112 7118	BEXXAR
T103	tradename 7406 7412	BEXXAR
T105	tradename 7542 7548	BEXXAR
T107	tradename 7840 7846	BEXXAR
T109	indication 7976 7998	Non-Hodgkin's Lymphoma
T111	tradename 8004 8010	BEXXAR
T113	nanoparticle 8033 8044	tositumomab
T115	activeingredient 8049 8061	iodine I 131
T117	nanoparticle 8062 8074	tositumomab)
T119	indication 8199 8221	non-Hodgkin's lymphoma
T121	indication 8322 8345	non-Hodgkin's lymphoma.
T123	tradename 8390 8396	BEXXAR
T125	tradename 8543 8549	BEXXAR
T127	tradename 8638 8644	BEXXAR
T129	tradename 8771 8777	BEXXAR
T131	tradename 8830 8836	BEXXAR
T133	indication 8933 8956	non-Hodgkin's lymphoma.
T135	tradename 8992 8998	BEXXAR
T137	nanoparticle 9054 9065	tositumomab
T139	activeingredient 9073 9085	iodine I 131
T141	nanoparticle 9086 9098	tositumomab)
T143	nanoparticle 9464 9475	Tositumomab
T145	dose 9476 9482	450 mg
T147	routeofadministration 9486 9497	intravenous
T149	nanoparticle 9514 9531	I-131 tositumomab
T151	dose 9533 9544	5 mCi I-131
T153	routeofadministration 9567 9578	intravenous
T155	nanoparticle 9665 9676	Tositumomab
T157	dose 9677 9683	450 mg
T159	routeofadministration 9687 9698	intravenous
T161	nanoparticle 9716 9733	I-131 tositumomab
T163	dose 9735 9741	35 mg)
T165	routeofadministration 9745 9756	intravenous
T167	activeingredient 9771 9781	iodine-131
T169	activeingredient 10077 10087	Iodine-131
T171	activeingredient 10247 10257	Iodine-131
T173	nanoparticle 10357 10368	Tositumomab
T175	nanoparticle 10555 10566	tositumomab
T177	dose 10588 10594	450 mg
T179	nanoparticle 10595 10606	tositumomab
T181	nanoparticle 10808 10819	tositumomab
T183	nanoparticle 10937 10948	tositumomab
T185	nanoparticle 11077 11094	I-131 Tositumomab
T187	nanoparticle 11349 11366	I-131 tositumomab
T189	nanoparticle 11457 11474	I-131 tositumomab
T191	nanoparticle 11598 11615	I-131 tositumomab
T193	nanoparticle 11816 11833	I-131 tositumomab
T195	activeingredient 12094 12105	Iodine-131.
T197	nanoparticle 12315 12332	I-131 tositumomab
T199	nanoparticle 12438 12455	I-131 tositumomab
T201	nanoparticle 12589 12600	tositumomab
T203	nanoparticle 12696 12713	I-131 tositumomab
T205	nanoparticle 12831 12842	tositumomab
T207	nanoparticle 12920 12931	tositumomab
T209	tradename 13943 13944	 
T211	nanoparticle 13944 13955	Tositumomab
T213	dose 14106 14112	450 mg
T215	nanoparticle 14113 14124	tositumomab
T217	routeofadministration 14158 14169	intravenous
T219	tradename 14622 14623	 
T221	nanoparticle 14623 14634	Tositumomab
T223	activeingredient 14684 14689	I-131
T225	nanoparticle 14690 14701	tositumomab
T227	activeingredient 14859 14864	I-131
T229	nanoparticle 14865 14876	tositumomab
T231	activeingredient 14935 14940	I-131
T233	nanoparticle 14941 14952	tositumomab
T235	nanoparticle 15010 15021	tositumomab
T237	activeingredient 15346 15351	I-131
T239	nanoparticle 15352 15363	tositumomab
T241	activeingredient 15928 15933	I-131
T243	nanoparticle 15934 15945	tositumomab
T245	activeingredient 16012 16024	Iodine I-131
T247	nanoparticle 16025 16036	tositumomab
T249	activeingredient 16276 16281	I-131
T251	nanoparticle 16283 16294	tositumomab
T253	compan 16367 16382	GlaxoSmithKline
T255	nanoparticle 16581 16592	tositumomab
T257	company 18501 18516	GlaxoSmithKline
T259	tradename 18517 18523	BEXXAR
T261	company 18688 18703	GlaxoSmithKline
T263	activeingredient 18807 18817	Iodine-131
T265	tradename 18928 18928	
T267	nanoparticle 18928 18939	Tositumomab
T269	dose 18943 18949	450-mg
T271	nanoparticle 18958 18969	tositumomab
T273	tradename 19053 19054	 
T275	nanoparticle 19055 19072	I-131 tositumomab
T277	nanoparticle 19290 19307	I-131 tositumomab
T279	nanoparticle 19397 19414	I-131 tositumomab
T281	activeingredient 19536 19541	I-131
T283	nanoparticle 19542 19553	tositumomab
T285	activeingredient 19721 19726	I-131
T287	nanoparticle 19727 19738	tositumomab
T289	activeingredient 19906 19911	I-131
T291	nanoparticle 19912 19923	tositumomab
T293	activeingredient 20181 20192	Iodine-131.
T295	activeingredient 20436 20441	I-131
T297	nanoparticle 20442 20453	tositumomab
T299	activeingredient 20566 20571	I-131
T301	nanoparticle 20572 20583	tositumomab
T303	activeingredient 20632 20637	I-131
T305	nanoparticle 20642 20653	tositumomab
T307	nanoparticle 20745 20756	tositumomab
T309	activeingredient 20840 20845	I-131
T311	nanoparticle 20846 20857	tositumomab
T313	nanoparticle 20955 20966	tositumomab
T315	nanoparticle 21026 21037	tositumomab
T317	nanoparticle 21133 21144	tositumomab
T319	tradename 21691 21691	
T321	nanoparticle 21691 21702	Tositumomab
T323	dose 21841 21847	450 mg
T325	nanoparticle 21848 21859	tositumomab
T327	routeofadministration 21893 21904	intravenous
T329	tradename 22344 22345	 
T331	activeingredient 22345 22350	I-131
T333	nanoparticle 22351 22362	Tositumomab
T335	activeingredient 22409 22414	I-131
T337	nanoparticle 22415 22426	tositumomab
T339	activeingredient 22578 22583	I-131
T341	nanoparticle 22584 22595	tositumomab
T343	activeingredient 22650 22655	I-131
T345	nanoparticle 22656 22667	tositumomab
T347	nanoparticle 22725 22736	tositumomab
T349	activeingredient 23054 23059	I-131
T351	nanoparticle 23060 23071	tositumomab
T353	activeingredient 23636 23641	I-131
T355	nanoparticle 23642 23653	tositumomab
T357	activeingredient 23723 23735	Iodine I-131
T359	nanoparticle 23736 23747	tositumomab
T361	activeingredient 23934 23939	I-131
T363	nanoparticle 23940 23951	tositumomab
T365	tradename 24228 24234	BEXXAR
T367	tradename 24338 24344	BEXXAR
T369	tradename 24385 24391	BEXXAR
T371	tradename 25185 25186	 
T373	nanoparticle 25186 25197	Tositumomab
T375	nanoparticle 25247 25258	Tositumomab
T377	nanoparticl 25313 25324	tositumomab
T379	activeingredient 25355 25365	Iodine-131
T381	nanoparticle 25468 25479	tositumomab
T383	nanoparticle 25568 25579	tositumomab
T385	activeingredient 25612 25622	Iodine-131
T387	nanoparticle 25722 25733	tositumomab
T389	tradename 25933 25939	BEXXAR
T391	tradename 26479 26485	BEXXAR
T393	tradename 26609 26615	BEXXAR
T395	tradename 26750 26756	BEXXAR
T397	tradename 27151 27157	BEXXAR
T399	tradename 27372 27378	BEXXAR
T401	activeingredient 27408 27419	Iodine-131.
T403	tradename 27582 27588	BEXXAR
T405	tradename 27778 27784	BEXXAR
T407	tradename 27932 27938	BEXXAR
T409	tradename 27994 28000	BEXXAR
T411	tradename 28194 28200	BEXXAR
T413	tradename 28555 28561	BEXXAR
T415	tradename 28787 28793	BEXXAR
T417	tradename 28891 28897	BEXXAR
T419	tradename 29463 29469	BEXXAR
T421	tradename 29682 29688	BEXXAR
T423	tradename 29799 29805	BEXXAR
T425	tradename 30060 30066	BEXXAR
T427	tradename 30314 30320	BEXXAR
T429	tradename 30394 30400	BEXXAR
T431	activeingredient 30488 30507	radiolabeled iodine
T433	nanoparticle 30656 30674	I-131 tositumomab.
T435	tradename 30851 30857	BEXXAR
T437	tradename 30928 30934	BEXXAR
T439	tradename 31118 31128	BEXXAR.  
T441	tradename 31255 31255	
T443	adversereaction 31255 31281	Serious Allergic Reactions
T445	adversereaction 31293 31304	Anaphylaxis
T447	tradename 31357 31357	
T449	adversereaction 31357 31388	Prolonged and Severe Cytopenias
T451	tradename 31488 31488	
T453	adversereaction 31488 31502	Hypothyroidism
T455	tradename 31602 31608	BEXXAR
T457	adversereaction 31675 31686	neutropenia
T459	adversereaction 31688 31704	thrombocytopenia
T461	adversereaction 31706 31712	anemia
T463	adversereaction 31715 31725	infections
T465	adversereaction 31737 31746	pneumonia
T467	adversereaction 31748 31758	bacteremia
T469	adversereaction 31760 31770	septicemia
T471	adversereaction 31772 31782	bronchitis
T473	adversereaction 31788 31804	skin infections)
T475	adversereaction 31807 31825	infusion reactions
T477	adversereaction 31827 31835	asthenia
T479	adversereaction 31837 31842	fever
T481	adversereaction 31848 31854	nausea
T483	tradename 31982 31988	BEXXAR
T485	adversereaction 32014 32045	severe and prolonged cytopenias
T487	adversereaction 32047 32057	infections
T489	adversereaction 32069 32078	pneumonia
T491	adversereaction 32080 32090	bacteremia
T493	adversereaction 32092 32102	septicemia
T495	adversereaction 32104 32114	bronchitis
T497	adversereaction 32120 32136	skin infections)
T499	adversereaction 32138 32164	serious allergic reactions
T501	adversereaction 32176 32188	bronchospasm
T503	adversereaction 32193 32204	angioedema)
T505	adversereaction 32206 32224	infusion reactions
T507	adversereaction 32230 32248	secondary leukemia
T509	adversereaction 32254 32278	myelodysplastic syndrome
T511	tradename 32700 32706	BEXXAR
T513	indication 32748 32770	non-Hodgkin's lymphoma
T515	tradename 33989 33995	BEXXAR
T517	tradename 34115 34115	
T519	adversereaction 34115 34123	Asthenia
T521	tradename 34131 34131	
T523	adversereaction 34131 34136	Fever
T525	tradename 34146 34146	
T527	adversereaction 34146 34155	Infection
T529	tradename 34168 34168	
T531	adversereaction 34168 34172	Pain
T533	tradename 34181 34181	
T535	adversereaction 34181 34187	Chills
T537	tradename 34196 34196	
T539	adversereaction 34196 34204	Headache
T541	tradename 34214 34214	
T543	adversereaction 34214 34228	Abdominal pain
T545	tradename 34238 34238	
T547	adversereaction 34238 34247	Back pain
T549	tradename 34256 34256	
T551	adversereaction 34256 34266	Chest pain
T553	tradename 34275 34275	
T555	adversereaction 34275 34284	Neck pain
T557	tradename 34323 34323	
T559	adversereaction 34323 34334	Hypotension
T561	tradename 34342 34342	
T563	adversereaction 34342 34356	Vasodilatation
T565	tradename 34390 34390	
T567	adversereaction 34390 34396	Nausea
T569	tradename 34406 34406	
T571	adversereaction 34406 34414	Vomiting
T573	tradename 34423 34423	
T575	adversereaction 34423 34431	Anorexia
T577	tradename 34440 34440	
T579	adversereaction 34440 34448	Diarrhea
T581	tradename 34457 34457	
T583	adversereaction 34457 34469	Constipation
T585	tradename 34477 34477	
T587	adversereaction 34477 34486	Dyspepsia
T589	tradename 34523 34523	
T591	adversereaction 34523 34537	Hypothyroidism
T593	tradename 34545 34546	 
T595	adversereaction 34546 34581	Metabolic and Nutritional Disorders
T597	tradename 34590 34590	
T599	adversereaction 34590 34606	Peripheral edema
T601	tradename 34615 34615	
T603	adversereaction 34615 34626	Weight loss
T605	tradename 34670 34670	
T607	adversereaction 34670 34677	Myalgia
T609	tradename 34691 34691	
T611	adversereaction 34691 34704	Arthralgia 10
T613	tradename 34734 34734	
T615	adversereaction 34734 34743	Dizziness
T617	tradename 34752 34752	
T619	adversereaction 34752 34762	Somnolence
T621	tradename 34799 34799	
T623	adversereaction 34799 34814	Cough increased
T625	tradename 34823 34823	
T627	adversereaction 34823 34834	Pharyngitis
T629	tradename 34843 34843	
T631	adversereaction 34843 34850	Dyspnea
T633	tradename 34859 34859	
T635	adversereaction 34859 34867	Rhinitis
T637	tradename 34877 34877	
T639	adversereaction 34877 34886	Pneumonia
T641	tradename 34923 34923	
T643	adversereaction 34923 34927	Rash
T645	tradename 34940 34940	
T647	adversereaction 34940 34948	Pruritus
T649	tradename 34957 34957	
T651	adversereaction 34957 34965	Sweating
T653	tradename 36480 36481	 
T655	adversereaction 36481 36513	Prolonged and Severe Cytopenias:
T657	tradename 36874 36875	 
T659	adversereaction 36875 36886	Infections:
T661	adversereaction 37022 37031	pneumonia
T663	adversereaction 37033 37043	bacteremia
T665	adversereaction 37046 37056	septicemia
T667	adversereaction 37058 37068	bronchitis
T669	adversereaction 37074 37130	skin infections. Allergic (Hypersensitivity) Reactions:
T671	adversereaction 37218 37235	allergic reaction
T673	adversereaction 37237 37249	facial edema
T675	adversereaction 37251 37282	injection site hypersensitivity
T677	adversereaction 37285 37306	anaphylactic reaction
T679	adversereaction 37308 37319	laryngismus
T681	adversereaction 37325 37340	serum sickness.
T683	adversereaction 37378 37396	Infusion reactions
T685	adversereaction 37407 37412	fever
T687	adversereaction 37414 37420	rigors
T689	adversereaction 37424 37430	chills
T691	adversereaction 37433 37441	sweating
T693	adversereaction 37443 37454	hypotension
T695	adversereaction 37456 37463	dyspnea
T697	adversereaction 37465 37477	bronchospasm
T699	adversereaction 37483 37489	nausea
T701	tradename 37760 37761	 
T703	adversereaction 37761 37785	Myelodysplastic Syndrome
T705	adversereaction 37792 37811	Secondary Leukemia:
T707	nanoparticle 39693 39705	tositumomab.
T709	indication 40248 40270	Non-Hodgkin's Lymphoma
T711	tradename 40285 40291	BEXXAR
T713	indication 40612 40634	non-Hodgkin's lymphoma
T715	tradenam 40652 40658	BEXXAR
T717	tradename 41090 41096	BEXXAR
T719	tradename 41285 41291	BEXXAR
T721	nanoparticle 41758 41769	tositumomab
T723	nanoparticle 41773 41795	I-131 499 tositumomab.
T725	tradename 41933 41939	BEXXAR
T727	tradename 42060 42066	BEXXAR
T729	activeingredient 42274 42279	I-131
T731	tradename 42354 42360	BEXXAR
T733	tradename 42471 42477	BEXXAR
T735	nanoparticle 42672 42683	tositumomab
T737	tradename 42934 42940	BEXXAR
T739	tradename 43078 43084	BEXXAR
T741	tradename 43177 43183	BEXXAR
T743	tradename 43291 43297	BEXXAR
T745	tradename 43493 43499	BEXXAR
T747	tradename 43809 43815	BEXXAR
T749	tradename 44001 44007	BEXXAR
T751	tradename 44255 44261	BEXXAR
T753	tradename 44341 44347	BEXXAR
T755	activeingredient 44488 44493	I-131
T757	tradename 44499 44505	BEXXAR
T759	activeingredient 44715 44720	I-131
T761	tradename 44738 44744	BEXXAR
T763	tradename 45027 45033	BEXXAR
T765	tradename 45078 45084	BEXXAR
T767	nanoparticle 45144 45155	tositumomab
T769	nanoparticle 45199 45217	I-131 tositumomab.
T771	tradename 45219 45219	
T773	nanoparticle 45219 45230	Tositumomab
T775	nanoparticle 45377 45388	tositumomab
T777	molecularweight 45392 45399	150 kD.
T779	tradename 45402 45402	
T781	nanoparticle 45402 45413	Tositumomab
T783	routeofadministration 45560 45571	intravenous
T785	inactiveingredient 45623 45630	maltose
T787	inactiveingredient 45642 45657	sodium chloride
T789	inactiveingredient 45667 45676	phosphate
T791	inactiveingredient 45686 45705	potassium hydroxide
T793	inactiveingredient 45711 45716	Water
T795	nanopartile 45768 45785	I-131 tositumomab
T797	nanoparticle 45789 45800	tositumomab
T799	activeingredient 45822 45833	Iodine-131.
T801	nanoparticle 45834 45851	I-131 tositumomab
T803	nanoparticle 45932 45949	I-131 tositumomab
T805	inactiveingredient 45976 45989	ascorbic acid
T807	inactiveingredient 46004 46011	maltose
T809	inactiveingredient 46047 46054	maltose
T811	inactiveingredient 46094 46102	povidone
T813	inactiveingredient 46125 46145	sodium 568 chloride.
T815	activeingredient 46225 46247	Iodine-131: Iodine-131
T817	activeingredient 46502 46512	Iodine-131
T819	activeingredient 46713 46723	Iodine-131
T821	activeingredient 46889 46900	Iodine-131:
T823	tradename 47146 47146	
T825	activeingredient 47146 47157	Tositumomab
T827	indication 47363 47387	non-Hodgkin's lymphomas.
T829	tradename 47498 47504	BEXXAR
T831	tradename 47976 47982	BEXXAR
T833	tradename 48653 48659	BEXXAR
T835	nanoparticle 48780 48797	I-131 tositumomab
T837	dose 48816 48822	475-mg
T839	dose 49003 49009	485 mg
T841	nanoparticle 49013 49024	tositumomab
T843	indication 49046 49069	non-Hodgkin's lymphomas
T845	clearance 49074 49084	68.2 mg/hr
T847	clearance 49093 49117	30.2 to 611 260.8 mg/hr)
T849	indication 49772 49794	non-Hodgkin's lymphoma
T851	eliminationhalflife 49799 49807	67 hours
T853	eliminationhalflife 49816 49832	28 to 115 hours)
T855	activeingredient 49851 49861	Iodine-131
T857	tradename 50278 50284	BEXXAR
T859	activeingredient 50377 50389	Iodine I-131
T861	tradename 50453 50459	BEXXAR
T863	tradename 50619 50625	BEXXAR
T865	tradename 51945 51951	BEXXAR
T867	indication 52601 52623	non-Hodgkin's lymphoma
T869	tradename 52900 52906	BEXXAR
T871	nanoparticle 53512 53523	tositumomab
T873	nanoparticl 53651 53669	I-131 tositumomab
T875	nanoparticle 53952 53963	tositumomab
T877	nanoparticle 54111 54130	677 131 tositumomab
T879	tradename 54258 54258	
T881	nanoparticle 54258 54270	Tositumomab:
T883	nanoparticle 54312 54323	tositumomab
T885	nanopartil 54444 54455	tositumomab
T887	tradename 54594 54594	
T889	nanoparticle 54594 54612	I-131 tositumomab:
T891	nanoparticle 54628 54645	I-131 tositumomab
T893	nanoparticle 54795 54812	I-131 tositumomab
T895	tradename 54921 54921	
T897	nanoparticle 54921 54938	I-131 tositumomab
T899	tradename 55938 55944	BEXXAR
T901	tradename 56181 56187	BEXXAR
T903	tradename 56569 56575	BEXXAR
T905	tradename 56681 56687	BEXXAR
T907	tradename 56756 56762	BEXXAR
T909	company 56792 56808	GlaxoSmithKline.
T911	company 56884 56899	GlaxoSmithKline
T913	company 56971 56987	GlaxoSmithKline.
